Molecular and Genetic Analysis of Lung Cancer

Description

Investigators use a genome-wide approach within a case-control design to identify SNPs that show evidence of association with lung cancer risk and survival.

Conditions

Lung Cancer

Study Overview

Study Details

Study overview

Investigators use a genome-wide approach within a case-control design to identify SNPs that show evidence of association with lung cancer risk and survival.

Molecular and Genetic Analysis of Lung Cancer

Molecular and Genetic Analysis of Lung Cancer

Condition
Lung Cancer
Intervention / Treatment

-

Contacts and Locations

Boston

Massachusetts General Hospital, Boston, Massachusetts, United States, 02114

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * healthy controls: participants without evidence of any cancer
  • * cases: pathology proven primary lung cancer
  • * younger than 18 years old

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Massachusetts General Hospital,

David C Christiani, MD, PRINCIPAL_INVESTIGATOR, Harvard TH Chan School of Public Health

Study Record Dates

2026-09